Delcath Systems Stock: Intriguingly Poised Ahead Of Q3 Earnings (NASDAQ:DCTH)
· seekingalpha.com
Delcath Systems Q3 earnings preview: topline beat odds look strong as CHOPIN trial success boosts growth outlook. Read here for more on DCTH stock.
Delcath Systems ( DCTH ) is a healthcare equipment business from the small-cap terrain (current market cap of $500M), whose proprietary interventional oncology ...